Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alper Sevinç, Metin Özkan, Ahmet Özet, Faysal Dane, Berna Öksüzoğlu, Abdurrahman Işıkdoğan, Feyyaz Özdemir, Doğan Uncu, Mahmut Gümüş, Türkkan Evrensel, Arzu Yaren, Oğuz Kara & Salim Başol Tekin. (2018) Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia. OncoTargets and Therapy 11, pages 419-426.
Read now
Read now
Alissa Huston & Gary H Lyman. (2007) Agents under investigation for the treatment and prevention of neutropenia. Expert Opinion on Investigational Drugs 16:11, pages 1831-1840.
Read now
Read now
Jorge Garbino, Aspasia Katragkou & Emmanuel Roilides. (2007) Immunomodulatory therapy in yeast infections. Expert Review of Anti-infective Therapy 5:1, pages 129-140.
Read now
Read now
Gary H Lyman. (2005) Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action. Expert Opinion on Biological Therapy 5:12, pages 1635-1646.
Read now
Read now
Articles from other publishers (24)
Natalie J. Alexander, David J. Bozym, Joceyln R. Farmer, Priscilla Parris, Adam Viens, Natalie Atallah, Alex Hopke, Allison Scherer, Zeina Dagher, Nicolas Barros, Sally A.I. Knooihuizen, Rebecca R. Saff, Mark S. Pasternack, Ryan W. Thompson, Daniel Irimia & Michael K. Mansour. (2021) Neutrophil functional profiling and cytokine augmentation for patients with multiple recurrent infections: A case study. The Journal of Allergy and Clinical Immunology: In Practice 9:2, pages 986-988.
Crossref
Crossref
Aspasia Katragkou, Thomas J. Walsh & Emmanuel Roilides. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
1019
1030
.
Ashutosh MukherjiAshutosh Mukherji. 2018. Basics of Planning and Management of Patients during Radiation Therapy. Basics of Planning and Management of Patients during Radiation Therapy
349
355
.
Matti Aapro, Carsten Bokemeyer, Heinz Ludwig, Pere Gasc?n, Mario Boccadoro, Kris Denhaerynck, Michael Gorray, Andriy Krendyukov, Karen MacDonald & Ivo Abraham. (2017) Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study). Journal of Geriatric Oncology 8:2, pages 86-95.
Crossref
Crossref
M. Aapro, H. Ludwig, C. Bokemeyer, P. Gascón, M. Boccadoro, K. Denhaerynck, A. Krendyukov, M. Gorray, K. MacDonald & I. Abraham. (2016) Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study). Annals of Oncology 27:11, pages 2039-2045.
Crossref
Crossref
Pere Gasc?n, Matti Aapro, Heinz Ludwig, Carsten Bokemeyer, Mario Boccadoro, Matthew Turner, Kris Denhaerynck, Karen MacDonald & Ivo Abraham. (2015) Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study). Supportive Care in Cancer 24:2, pages 911-925.
Crossref
Crossref
Inna Vainshtein, Lorin K. Roskos, Jackie Cheng, Matthew A. Sleeman, Bing Wang & Meina Liang. (2014) Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals. Pharmaceutical Research 32:1, pages 286-299.
Crossref
Crossref
Eun-Joo Kang, Nam-Ki Choi & Seon-Mi Kim. (2013) ORAL FINDINGS AND TREATMENT OF A PATIENT WITH CYCLIC NEUTROPENIA. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY 40:2, pages 133-140.
Crossref
Crossref
Charalampos Antachopoulos, Aspasia Katragkou & Emmanuel Roilides. (2012) Immunotherapy against invasive mold infections. Immunotherapy 4:1, pages 107-120.
Crossref
Crossref
Yongping Jiang, Wenhong Jiang, Yuchang Qiu & Wei Dai. (2011) Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys. Journal of Hematology & Oncology 4:1.
Crossref
Crossref
Pere Gascón, Matti Aapro, Heinz Ludwig, Nadia Rosencher, Matthew Turner, MinKyoung Song, Karen MacDonald, Christopher Lee, Michael Muenzberg & Ivo Abraham. (2011) Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim. Critical Reviews in Oncology/Hematology 77:3, pages 184-197.
Crossref
Crossref
C. Falandry, M. Campone, G. Cartron, D. Guerin & G. Freyer. (2010) Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines. European Journal of Cancer 46:13, pages 2389-2398.
Crossref
Crossref
Mohammad Shahid, Trivendra Tripathi, Nancy Khardori, Anwar Huq & Iqbal Ahmad. 2010. Combating Fungal Infections. Combating Fungal Infections
373
396
.
Gary H. Lyman. 2011. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology
109
125
.
S Kelly & D Wheatley. (2009) Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors. British Journal of Cancer 101:S1, pages S6-S10.
Crossref
Crossref
Ruth Pettengell, Matti Aapro, Ercole Brusamolino, Dolores Caballero, Bertrand Coiffier, Michael Pfreundschuh, Marek Trneny & Jan Walewski. (2009) Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care. Clinical Drug Investigation 29:8, pages 491-513.
Crossref
Crossref
Ruth Pettengell, André Bosly, Thomas D. Szucs, Christian Jackisch, Robert Leonard, Robert Paridaens, Manuel Constenla & Matthias Schwenkglenks. (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study. British Journal of Haematology 144:5, pages 677-685.
Crossref
Crossref
Lew M. IacovelliBrandy L. Persson. (2008) Management of Chemotherapy-Induced Neutropenia: Opportunities for Pharmacist Involvement. Hospital Pharmacy 43:6, pages 472-484.
Crossref
Crossref
Christoph C. Zielinski, Ahmad Awada, David A. Cameron, Tanja Cufer, Miguel Martin & Matti Aapro. (2008) The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients. European Journal of Cancer 44:3, pages 353-365.
Crossref
Crossref
P. Caraceni, F. Giannone, L. Catani, S. Talarico, A.M. Pertosa, M. Domenicali, M. Fogli, A. Principe, F. Trevisani, M. Baccarani, M. Bernardi & R.M. Lemoli. (2007) Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. Digestive and Liver Disease 39:10, pages 943-951.
Crossref
Crossref
M.S. Aapro, D.A. Cameron, R. Pettengell, J. Bohlius, J. Crawford, M. Ellis, N. Kearney, G.H. Lyman, V.C. Tjan-Heijnen, J. Walewski, D.C. Weber & C. Zielinski. (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. European Journal of Cancer 42:15, pages 2433-2453.
Crossref
Crossref
George D. Demetri. 2006. Oncology. Oncology
1535
1544
.
Lena M. Napolitano. (2005) Immune Stimulation in Sepsis. Chest 127:6, pages 1882-1885.
Crossref
Crossref
Charalampos Antachopoulos & Emmanuel Roilides. (2005) Cytokines and fungal infections. British Journal of Haematology 129:5, pages 583-596.
Crossref
Crossref